Biliary cancer: Utility of next-generation sequencing for clinical management.
about
The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinomaFrom Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersNew Horizons for Precision Medicine in Biliary Tract Cancers.Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.Current biologics for treatment of biliary tract cancers.Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.Targeting cholangiocarcinoma.Predicting Resectability in Gallbladder Cancer: the Tata Memorial Hospital Staging System.New molecular and immunotherapeutic approaches in biliary cancer.Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.Emerging role of precision medicine in biliary tract cancers
P2860
Q33656860-DBA687EF-D0BF-43BA-B9D2-E9085AEA0E42Q33888883-C5CE3D94-FF47-4A14-8A50-900FC484B4FBQ37631655-80E603C9-7297-45A4-B43A-4A6F69FA005DQ38619219-0F0CB72E-4A70-4F69-9EED-76B0D1E5B6CCQ38673037-BB456F7B-AF8A-430E-A242-9743A564CBA5Q39453572-52B54961-C458-4835-B913-02AA0C328441Q49627919-1747488B-22EF-4F46-B891-255D0871098BQ49952154-F99C3946-A734-4AF4-9AD4-AEFF7569F6EAQ49952320-DA14A821-7FB7-44E9-A467-870A38188E3BQ52757760-ED089BF1-B959-48FF-9845-B3173DEE3D9FQ53099877-ECEE7CC5-F93E-46EC-9AB2-D0E567C162FBQ54476966-210B710B-31B8-4BE5-8B57-FED6C6109794Q55523920-9D6CCE7A-9598-4FE5-A89F-4B07545C2522Q57298169-8051D27D-8AC8-4BB0-8390-48D4F9C88516
P2860
Biliary cancer: Utility of next-generation sequencing for clinical management.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Biliary cancer: Utility of next-generation sequencing for clinical management.
@en
Biliary cancer: Utility of next-generation sequencing for clinical management.
@nl
type
label
Biliary cancer: Utility of next-generation sequencing for clinical management.
@en
Biliary cancer: Utility of next-generation sequencing for clinical management.
@nl
prefLabel
Biliary cancer: Utility of next-generation sequencing for clinical management.
@en
Biliary cancer: Utility of next-generation sequencing for clinical management.
@nl
P2093
P2860
P356
P1433
P1476
Biliary cancer: Utility of next-generation sequencing for clinical management.
@en
P2093
Ahmed Kaseb
Andrea Grace Bocobo
Apurva Jain
Daniel Ahn
Daniel Catenacci
Hyunseon C Kang
Jeffrey Ross
Milind Javle
Mingxin Zuo
P2860
P304
P356
10.1002/CNCR.30254
P407
P577
2016-09-13T00:00:00Z